Vomifraton 4mg / 2ml Ampoules for IV, IM or infusion 8mg / 4ml Ampoules for IV, IM or infusion

Quote:

The Active Pharmaceutical ingredients is (Ondansetron).

Vomifraton is indicated in adults for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting (PONV).

Vomifraton is indicated Pediatric Population for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥6 months, and for the prevention and treatment of PONV in children aged ≥1 month.